FDA ‘Expedited Review’ Would Shave Off Additional Month For Some ‘Breakthrough’ Products
FDA appears to be establishing new regulatory paradigm – albeit one that is not laid out in statute officially.
FDA appears to be establishing new regulatory paradigm – albeit one that is not laid out in statute officially.